Identification of Insulin Resistance Biomarkers in Metabolic Syndrome Detected by UHPLC-ESI-QTOF-MS

Metabolic syndrome (MetS) is a disorder characterized by a group of factors that can increase the risk of chronic diseases, including cardiovascular diseases and type 2 diabetes mellitus (T2D). Metabolomics has provided new insight into disease diagnosis and biomarker identification. This cross-sect...

Descripción completa

Detalles Bibliográficos
Autores principales: Alsoud, Leen Oyoun, Soares, Nelson C., Al-Hroub, Hamza M., Mousa, Muath, Kasabri, Violet, Bulatova, Nailya, Suyagh, Maysa, Alzoubi, Karem H., El-Huneidi, Waseem, Abu-Irmaileh, Bashaer, Bustanji, Yasser, Semreen, Mohammad H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227428/
https://www.ncbi.nlm.nih.gov/pubmed/35736441
http://dx.doi.org/10.3390/metabo12060508

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227428/
https://www.ncbi.nlm.nih.gov/pubmed/35736441
http://dx.doi.org/10.3390/metabo12060508

Ejemplares similares